Start-up, Organization and Performance of a Multidisciplinary Pulmonary Embolism Response Team for the Diagnosis and Treatment of Acute Pulmonary Embolism

Pulmonary embolism (PE) is a life-threatening condition and a leading cause of morbidity and mortality. There have been many advances in the field of PE in the last few years, requiring a careful assessment of their impact on patient care. However, variations in recommendations by different clinical guidelines, as well as lack of robust clinical trials, make clinical decisions challenging. The Pulmonary Embolism Response Team Consortium is an international association created to advance the diagnosis, treatment, and outcomes of patients with PE. In this consensus practice document, we provide a comprehensive review of the diagnosis, treatment, and follow-up of acute PE, including both clinical data and consensus opinion to provide guidance for clinicians caring for these patients.

Download Full-text

Management of Acute Pulmonary Embolism With a Pulmonary Embolism Response Team

The Journal of the American Board of Family Medicine ◽

10.3122/jabfm.2021.02.200308 ◽

2021 ◽

Vol 34 (2) ◽

pp. 402-408

Author(s):

Jason R. Cuomo ◽

Vishal Arora ◽

Thad Wilkins

Keyword(s):

Pulmonary Embolism ◽

Acute Pulmonary Embolism ◽

Response Team ◽

Pulmonary Embolism Response Team

Download Full-text

ASSOCIATIONS BETWEEN OUTCOMES AND DISCHARGE ANTICOAGULATION IN ACUTE PULMONARY EMBOLISM PATIENTS MANAGED BY THE PULMONARY EMBOLISM RESPONSE TEAM (PERT)

CHEST Journal ◽

10.1016/j.chest.2018.08.928 ◽

2018 ◽

Vol 154 (4) ◽

pp. 1029A

Author(s):

ADAM ROTHMAN ◽

JASON FILOPEI ◽

JOHN KILECI ◽

ERIC BONDARSKY ◽

DI PAN ◽

...

Keyword(s):

Pulmonary Embolism ◽

Acute Pulmonary Embolism ◽

Response Team ◽

Pulmonary Embolism Response Team

Download Full-text

Impact of Pulmonary Embolism Response Team on Anticoagulation Prescribing Patterns in Patients With Acute Pulmonary Embolism

Journal of Pharmacy Practice ◽

10.1177/0897190020940125 ◽

2020 ◽

pp. 089719002094012

Author(s):

Shannon Kuhrau ◽

Dalila Masic ◽

Erin Mancl ◽

Yevgeniy Brailovsky ◽

Katerina Porcaro ◽

...

Keyword(s):

Pulmonary Embolism ◽

Acute Pulmonary Embolism ◽

Treatment Options ◽

Prescribing Patterns ◽

Multiple Treatment ◽

Response Team ◽

Treatment Plans ◽

Multidisciplinary Group ◽

Pulmonary Embolism Response Team ◽

Selection Of

Introduction: Anticoagulation remains the mainstay pharmacotherapy for acute pulmonary embolism (PE), but multiple treatment options exist. The Pulmonary Embolism Response Team (PERT) is a multidisciplinary group that evaluates patients, formulates evidence-based treatment plans, and mobilizes resources. The objective of this study was to characterize the anticoagulation prescribing patterns made by PERT and to determine the clinical impact of anticoagulant selection. Materials and Methods: This was a retrospective analysis of patients evaluated by PERT from 2016 to 2018. Multivariable linear regression was conducted to determine predictors of length of stay (LOS). Results: A total of 209 patients were evaluated by PERT and received anticoagulation on discharge. Of those, 47% received a non-vitamin K oral anticoagulant (NOAC), 29% received warfarin, and 23% received low-molecular-weight heparin. Patient preferences and comorbidities were the most common reasons for NOAC omission. Patients who received NOACs had a shorter median LOS than warfarin (6.1 [4.6-7.6] days vs 10.9 [8.4-13.4] days; P < .05). Selection of NOAC upon discharge was the only factor independently associated with reduced LOS (β coefficient: −0.6; 95% CI: −1.01 to −0.18; P < .01). Conclusion: The most common recommendation made by PERT was to initiate a NOAC upon discharge, resulting in shorter hospital LOS compared to patients who received warfarin.

Download Full-text